Navigation Links
Vince & Associates, Brad Vince Expands Early Phase Gastrointestinal Capabilities
Date:8/28/2013

Overland Park, KS (PRWEB) August 28, 2013

Vince & Associates Clinical Research, a premier provider of early phase clinical research services to the global biopharmaceutical industry, announced today the expansion of its capabilities in the gastrointestinal (GI) therapeutic area with the addition of a dedicated Endoscopy Suite at its Clinical Pharmacology Unit.

"Vince and Associates Clinical Research has successfully conducted a number of studies evaluating potential therapies in patients with gastrointestinal disorders. To supplement ongoing research, VACR has established an Endoscopy Suite to offer on-site access to a wide range of endoscopic procedures," said Dr. Brad Vince, CEO and medical director of Vince & Associates. "This investment reaffirms our dedication to providing research expertise in response to increasing demand for conducting clinical research in patient populations during early development, which often requires more specialized techniques."

The suite is equipped with advanced and minimally invasive video endoscopy technology from Olympus EndoTherapy. Procedures can be viewed remotely on a large screen and documented by video or still photography. The suite includes two sources of suction as well as resuscitation and medication stations to address patient safety and equipment is maintained at the purpose built disinfection station.

In addition to creating the Endoscopy Suite, VACR has reached out to Summit Gastroenterology for their medical expertise to complement the new research capabilities. Their Board Certified Gastroenterologists have been asked to join the Vince & Associates Clinical Research team as investigators, bringing significant clinical expertise as GI specialists.

Dr. Brad Vince stated, "The endoscopy suite and additional medical expertise significantly broaden the clinical research capabilities we are able to offer our clients. This investment will be key for clients seeking to obtain safety and efficacy data in patients and healthy normal volunteers during the early development phase to more quickly reach sound drug development decisions."

About Vince & Associates Clinical Research

Vince & Associates Clinical Research has provided clinical research services to the biopharmaceutical industry for more than a decade. Proud to be recognized in the industry as a "Center of Research Excellence", Vince & Associates has become a premier clinical research site by utilizing The Physician Research Model® of operation where study teams are led by highly experienced principal investigators intimately involved in all aspects of the clinical trial process.

Vince & Associates operates a state-of-the-art, multimillion-dollar, 90-bed clinical pharmacology unit that combines the ultimate in subject safety and luxury. This unit has the upscale atmosphere necessary for the recruitment and retention of study volunteers in both short- and long-term clinical trials, from the safety and security of the controlled access unit to the added features of a movie theater and game rooms.

About Altasciences

Altasciences is the parent company of wholly owned subsidiaries Vince & Associates Clinical Research (Kansas, USA) and Algorithme Pharma (Quebec, Canada). Both organizations provide comprehensive early stage clinical services in Phase I/IIa, including the necessary support services in this critical stage of drug development.

Read the full story at http://www.prweb.com/releases/brad-vince/research-expansion/prweb11067076.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Bradley Vince of Vince & Associates in Kansas City Featured in Prominent Clinical Research Magazine
2. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
3. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
4. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
5. St. Vincent, Austen BioInnovation Institute Announce Strategic Partnership to Develop New Products
6. China Green Agriculture Inc. Presented at Farmer Dailys Branded Fertilizer Roadshow in Shaanxi Province
7. HemoShear Hires Industry Business Development Veteran Vincent Aurentz as Chief Business Officer
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... 2016 A person commits a crime, and the ... track the criminal down. An outbreak of foodborne ... Administration (FDA) uses DNA evidence to track down the bacteria ... far-fetched? It,s not. The FDA has increasingly used a complex, ... foodborne illnesses. Put as simply as possible, whole genome sequencing ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):